RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITEDSET: RAM🇹🇭 TH

MD&A · 2025

Overview of Operations

Overview of Operations

In 2025, Thailand’s private hospital industry remained highly competitive amid an increasing number of providers, rising expectations for medical quality, and more discerning healthcare consumers. The gradual economic recovery continued to affect purchasing power, particularly among self-paying patients, intensifying competition in pricing, service differentiation, and cost efficiency. In response, Ramkhamhaeng Hospital Public Company Limited advanced its RAM 2.0 strategy to strengthen long-term competitiveness through operational efficiency, expansion of higher-value medical services, and network integration. The Company increased its investment in Thonburi Healthcare Group Public Company Limited in August 2025 and in Chiangmai Ram Hospital Company Limited in December 2025, resulting in a change in status from associates to subsidiaries. The consolidation enhances synergies in patient referrals, shared medical resources, knowledge exchange, and cost management, supporting stable and sustainable growth in a challenging competitive environment.

Operating Results & Financial Condition

Operating Results & Profitability

In 2025, the Company reported total revenue of THB 16,791.7 million, increasing 64.2% YoY. Total operating revenue amounted to THB 14,751.7 million, increasing 49.5% YoY, primarily driven by the increased equity stakes in Thonburi Healthcare Group Public Company Limited (THG) and Chiangmai Ram Hospital Company Limited (CMH), resulting in their consolidation as subsidiaries. Excluding contributions from THG and CMH, operating revenue totaled THB 10,618.0 million, increasing 7.6% YoY. EBITDA amounted to THB 5,447.9 million, increasing 131.9% YoY, while net profit attributable to the parent totaled THB 2,797.8 million, increasing 284.4% YoY, reflecting the same consolidation effect. Excluding special items, normalized EBITDA amounted to THB 3,813.8 million, and normalized net profit attributable to the parent totaled THB 1,163.8 million, respectively.

Liquidity & Capital Adequacy

  • Net cash generated from operating activitieswas THB 2,551.8 million, increasing by THB 902.6 million YoY, primarily driven by improved operating performance following the consolidation of THG and CMH, as well as more effective working capital management, resulting in higher cash collections compared with the prior year.

  • Net cash generated from investing activitieswas THB 2,591.8 million, primarily attributable to partial disposals of investments and dividend income received.

  • Net cash generated used in financing activitieswas THB 3,607.1 million, mainly from repayments of short-term and long-term borrowings from financial institutions, which were largely financed by proceeds from such investment disposals.

Asset Management Capability

Following the increase in shareholding in THG and CMH, as previously discussed, the Company’s financial position was significantly impacted as follows:

Total Assets as of 31 December 2025 amounted to THB 63,748.1 million, increasing by THB 22,457.6 million, or 54.4%, compared with 31 December 2024. The increase was primarily attributable to:

  1. Current Assets,which increased by THB 3,901.3 million, mainly due to higher cash and cash equivalents of THB 1,536.5million, trade receivables of THB 999.8 million, and inventories of THB 865.3 million.

  2. Non-current assets,which increased by THB 18,556.4million, primarily driven by increases in property, plant and equipment of THB 13,999.1 million, goodwill of THB 6,032.1 million, investment properties of THB 2,140.8 million, and right-of-use assets and intangible assets totaling THB 1,608.9 million. However, Investments in associates decreased by THB 5,449.4 million due to reclassification to subsidiaries, while investments in joint ventures increased by THB 706.7 million, mainly from ArYu International Pte. Ltd. Equity investments at FVOCI decreased by THB 1,451.2 million following disposals.

Total Liabilities as of 31 December 2025 amounted to THB 23,957.7 million, increasing by THB 9,607.4 million, or 66.9%, compared with 31 December 2024. The increase was primarily attributable to:

  1. Current liabilities, which increased by THB 6,610.6 million, mainly from short-term borrowings of THB 3,511.5 million obtained as bridge loans to finance the acquisition of additional shares in Thonburi Healthcare Group Public Company Limited, higher current portions of long-term borrowings of THB 667.0 million, and an increase in trade payables of THB 1,639.6 million following consolidation. Corporate income tax payable also increased by THB 484.6 million.

  2. Non-current liabilities, which increased by THB 2,908.0 million, primarily due to increases in long-term borrowings and debentures totaling THB 2,279.4 million, and provisions for employee benefits of THB 597.5 million, largely resulting from the consolidation of the two subsidiaries.

Total Shareholders' Equity as of 31 December 2025 amounted to THB 39,790.4 million, increasing by THB 12,850.3 million, or 47.7%, primarily driven by improved operating performance and the reclassification of two associates to subsidiaries. The shift from the equity method to full consolidation under the acquisition method significantly expanded the consolidated equity base.

Debt Securities with Financial Ratio Requirements

Debt Securities with Financial Ratio Requirements Issued?

No

Factors That May Affect Financial Condition

Factors or Incidents That May Materially Affect Financial Condition

In 2026, the Company will transition to operating as a “group” by organizing its management structure into four hospital groups: (1) Ramkhamhaeng Hospital Group, (2) Vibharam Hospital Group, (3) Chiang Mai Ram Hospital Group, and (4) Thonburi Hospital Group. This restructuring is intended to enhance governance, resource allocation, and performance management under a unified direction and consistent standards across the Group.

The Company will also begin driving selective “centralization” of appropriate support functions to improve operational efficiency, reduce duplicated costs, and strengthen internal control systems in a consistent manner throughout the network. The Company views 2026 as a “year of foundation building” for group-wide operations, including establishing shared key policies and core processes, developing operating standards, enhancing approval and oversight mechanisms, and building performance monitoring and evaluation systems to support the Group’s long-term expansion. In addition, the Company remains committed to continued network expansion and will consider internal shareholding restructuring to support further M&A activities, as well as strengthening the operating capabilities of each hospital group to enhance competitiveness and achieve sustainable growth going forward.

From a financial structure perspective, the Company plans to undertake financial restructuring to enhance flexibility and strengthen its financial position, with a focus on preparing for a corporate credit rating and expanding funding channels through the debt capital markets. These initiatives are intended to support the Group’s investment plans, network expansion, and liquidity management in line with its long-term growth strategy.

The Company will operate under its vision: “Aiming to be Thailand’s leading health network, delivering international medical standards accessible to everyone, growing sustainably alongside Thai society” In this regard, the Company places importance on enhancing the quality of medical care, improving access to healthcare services, and creating long-term value for all stakeholders in tandem.

Projects or R&D Affecting Future Results

-

Contents